Australia markets closed

ResMed Inc. (RMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
211.73-0.65 (-0.31%)
At close: 04:00PM EDT
211.15 -0.58 (-0.27%)
After hours: 06:14PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
4,584,159
4,222,993
3,578,127
3,196,825
2,957,013
-
Cost of revenue
2,026,996
1,867,331
1,553,816
1,357,725
1,239,227
-
Gross profit
2,557,163
2,355,662
2,024,311
1,839,100
1,717,786
-
Operating expenses
Research development
304,808
287,642
253,575
225,284
201,946
-
Selling general and administrative
915,634
874,003
737,508
670,387
676,689
-
Total operating expenses
1,268,020
1,203,665
1,022,161
926,749
908,727
-
Operating income or loss
1,289,143
1,151,997
1,002,150
912,351
809,059
-
Interest expense
-
-
-
23,989
40,377
36,156
Total other income/expenses net
-50,545
-2,954
-19,355
-5,062
-36,615
-
Income before tax
1,183,868
1,101,664
960,483
883,662
733,088
-
Income tax expense
225,489
204,108
181,046
409,157
111,414
-
Income from continuing operations
958,379
897,556
779,437
474,505
621,674
-
Net income
958,379
897,556
779,437
474,505
621,674
-
Net income available to common shareholders
958,379
897,556
779,437
474,505
621,674
-
Basic EPS
6.17
6.12
5.34
3.27
4.31
-
Diluted EPS
6.15
6.09
5.30
3.24
4.27
-
Basic average shares
146,926
146,765
146,066
145,313
144,338
-
Diluted average shares
147,543
147,455
147,043
146,451
145,652
-